RT @Keimgehalt: #Coronavirus: Forscher der Uni Oxford haben Ergebnisse erster #Impfstoff-Tests vorgestellt: Experten sehen gute Chancen, da…
#EnsayosVacunas #Covid-19 La vacuna de la Universidad de Oxford produce una fuerte respuesta inmune y es segura en ensayos preliminares
RT @BiotechMania: 中国カンシノ社が開発中のアデノウイルスベクターのCOVID-19ワクチンの第2相試験結果がLancetに掲載。 死亡率が高く最も重要な対象年齢である55歳以上で明らかに免疫反応が劣り、中和抗体陽性抗体価・陽性率が低いことは要注意だろう。 ht…
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet https://t.co/oOiYICa9qW
💉🧬نتائج المرحلة الثانية(فاعلية تحفيز المناعة) لتطعيم 💉Ad5 vectored COVID-19💉 https://t.co/lZ1cWZh8bK ✅تأكيد المأمونية 👍تحفيز ملحوظ للخلايا التائية المناعية المستهدفة للفايروس في90%من المشاركين(مؤشر لتأثير وقائي فعلي) ⚠️انتاج الاجسام المضادة تأثر بالعمر(أكب
#Coronavirus: Forscher der Uni Oxford haben Ergebnisse erster #Impfstoff-Tests vorgestellt: Experten sehen gute Chancen, dass das Mittel vor schweren #Covid19-Verläufen schützen könnte & "akzeptables Sicherheitsprofil" @tagesschau @NDRrecherche @TheLan
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @TheLancet: Phase 3 trials are needed to confirm whether the vaccine candidate effectively protects against SARS-CoV-2 infection https:/…
نتائج مشجعه للقاح الصيني في المرحلة الثانيه من الدراسة. قد توثر الاصابه مسبقا بفيروس الادينوفايرس ٥ المستخدم كناقل للقاح بمخرجات المناعه. زيادة الجراه قد تكون الحل https://t.co/rJEptTcPy2
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @Sintapabocas1: VACUNA DE EMPRESA CHINA CANSINO BIOLOGICS GENERO RESPUESTA INMUNE. Como en la de Oxford y AstraZeneca, quedan preguntas…
VACUNA DE EMPRESA CHINA CANSINO BIOLOGICS GENERO RESPUESTA INMUNE. Como en la de Oxford y AstraZeneca, quedan preguntas sobre cuánto durará una respuesta inmune y cómo las vacunas afectarán a las poblaciones más afectadas por Covid-19. @acinnacional htt
RT @norionakatsuji: この論文ですね。https://t.co/nFQK9uh7dn
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
in case youre interested in the other study: the Phase 1 trial: https://t.co/5Ff5FXO8zs the Phase 2 trial, also just published! I actually havent gotten a chance to look at it yet: https://t.co/L2Z9R3kL3r
RT @infecto79: Resultados muy prometedores de la vacuna con base en vectores "Ad5-vectored COVID-19 vaccine" a dosis de 5 × 10¹⁰ ...en ma…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @iaiestaran: Vacuna china en fase 2 resulta segura y produce respuesta inmune en la epidemia de coronavirus #COVID19, según estudio publ…
この論文ですね。https://t.co/nFQK9uh7dn
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @EricTopol: And another adenovirus vector vaccine Phase 2 trial (CanSIno) in China, published @TheLancet today, also found neutralizing…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
recombinant adenovirus type-5-vectored #COVID-19 vaccine in healthy adults is safe & immunogenic- phase 2 results looking good https://t.co/UmljlHDHRk
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @sophieesmall: For anyone as nerdy as me, I'm always pleasantly surprised by the clarity of scientific articles, so I recommend giving t…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial https://t.co/reZYU5zjVZ
RT @MinatoNakazawa: 原著論文は https://t.co/mudsNZi4Uf だが,Lancetの同じ号には,中国発のワクチン候補の第2相臨床試験も安全で有効だったとする原著論文も載っている https://t.co/3iQbFRTGBG 第3相でどうなる…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
I meant to add this to my other thread. The numbers for CanSino are worse than Chadox. I presume this is because CanSino uses a Human Adv (some some people already have immunity). But Chadox is a chimp Adv that most people haven’t seen before. mRNA mig
RT @MonsieurQFB: Por la mañana tuvimos la publicación de los resultados de Fase I/II de la vacuna de Oxford - AstraZeneca ( https://t.co/dE…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @AndyBiotech: #COVID19 The most interesting data point in Cansino Ph2 is that we see data for the 1st time for the most vulnerable older…
RT @TheLancet: Phase 3 trials are needed to confirm whether the vaccine candidate effectively protects against SARS-CoV-2 infection https:/…
Lancet report on CanSino vaccine from China. 👉The Ad5-vectored COVID-19 vaccine at 5 × 1010 viral particles is safe, and induced significant immune responses in the majority of recipients after a single immunisation. https://t.co/DMziWJPGiX
Nossa grande esperança...
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @LLopezGonzalez: 4/4 Another experimental #COVID19 vaccine in China also released promising early results when researchers tested to see…
RT @FabBallarini: BUENAS NOTICIAS Se acaban de publicar 2 papers contando los avances sobre 2 vacunas. En ambos casos se muestra respuest…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @carpe_diem0820: 中国でCanSino Biologicsが開発するAdV5型ベクターを用いたCOVID-19ワクチン第2相試験 1回接種で28日目までにほぼ全員の抗体が陽転し、有意な中和抗体反応を示す Immunogenicity and safety…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @iaiestaran: Vacuna china en fase 2 resulta segura y produce respuesta inmune en la epidemia de coronavirus #COVID19, según estudio publ…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial https://t.co/HLTvLKnoNU
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @EricTopol: And another adenovirus vector vaccine Phase 2 trial (CanSIno) in China, published @TheLancet today, also found neutralizing…
Phase 2 human trail data from the two adenovirus vectored #COVID19 #vaccines from Oxford (https://t.co/dF6sUlxRXt) and Cansino (https://t.co/eHa9ShGLiW ), respectively.
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
La de Oxford compite cabeza a cabeza con la de los chinos y la de los rusos que aparentemente también está bastante avanzada según leí por ahí. Moderna quedó rezagada?
RT @EricTopol: And another adenovirus vector vaccine Phase 2 trial (CanSIno) in China, published @TheLancet today, also found neutralizing…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @MonsieurQFB: Hoy también se publicaron los resultados de fase II de la vacuna de CanSino en la misma revista y también se encontraron a…
RT @RebeccaRambar: Chine : Une étude du Lancet indique qu'un essai chinois de phase 2 révèle que le vaccin COVID-19 est sûr et induit une r…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
2 vaccine candidates published yesterday good immune response in early trials, but there is still a long way to go. The Chinese company CanSino Biologics https://t.co/JDK7W1Hz3P and the Oxford University and the British-Swedish drug maker AstraZeneca
オックスフォードの試験結果論文 Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial https://t.co/HpILCJEn4T
RT @AssalaLamaa: لقاح CanSino: https://t.co/lPAGAx45tU https://t.co/zkQoqR1w4s
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
Two vaccine candidates published yesterday good immune response in early trials, but there is still a long way to go. The Chinese company CanSino Biologics https://t.co/a3h9lyvXMo and the Oxford University and the British-Swedish drug maker AstraZeneca htt
RT @4ndresRivera: Cada vez va tomando más fuerza la noticia de la vacuna de Oxford. Solo hace falta una prueba más, primero Dios todo salga…
RT @MonicaMrestrem: Resultados alentadores vacuna fase 1/2 universidad de Oxford
Informe similar al de Oxford de esta tarde. Datos alentadores de una vacuna china. PD: Ginés habría contactado con Oxford para probar su vacuna en el país.
#Covid_19 updates RNA vaccine: https://t.co/9aCTJpDD4G Oxford vaccine: https://t.co/PotQRXK25M Wuhan vaccine: https://t.co/b9F6IyO9Av Cardiac arrest: https://t.co/ozrZcmdSnR @drharshvardhan @ICMRDELHI @MoHFW_INDIA #COVID19 #COVIDー19 #coronavirus #vaccine
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: Phase 3 trials are needed to confirm whether the vaccine candidate effectively protects against SARS-CoV-2 infection https:/…
RT @TheLancet: The primary objective of the study was to evaluate the immune response and safety of the vaccine, and to determine the most…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @EricTopol: And another adenovirus vector vaccine Phase 2 trial (CanSIno) in China, published @TheLancet today, also found neutralizing…
A quien le pueda interesar, 603 voluntarios, de los cuales se eligieron 508 para recibir la vacuna, la cual tuvo una respuesta de anticuerpos neutralizantes, actualmente documentado hasta el día 28 desde el punto A. Fuente. https://t.co/ye86Prk1ik https://
RT @infecto79: Resultados muy prometedores de la vacuna con base en vectores "Ad5-vectored COVID-19 vaccine" a dosis de 5 × 10¹⁰ ...en ma…
RT @LLopezGonzalez: 4/4 Another experimental #COVID19 vaccine in China also released promising early results when researchers tested to see…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @4ndresRivera: Cada vez va tomando más fuerza la noticia de la vacuna de Oxford. Solo hace falta una prueba más, primero Dios todo salga…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @SIDPharm: Check out the phase 1/2 vaccine trials published in @TheLancet today #COVID19 #IDTwitter ChAdOx1 https://t.co/HhLxI684bs Ad…
RT @AB_Algaissi: أخبار جميلة اليوم عن اللقاحات: نشر نتائج المرحلة السريرية ١ للقاح جامعة أكسفورد والنتائج مشجعة جداً. https://t.co/qzBJVYI…